Polycystic Ovary Syndrome Is a Challenging Problem in Women
DOI:
https://doi.org/10.22270/ajprd.v11i6.1325Keywords:
Polycystic ovarian syndrome, oxidative stress, clinical Problems, Medicinal plantsAbstract
A diverse endocrine condition, polycystic ovarian syndrome is characterised by ovarian cysts, anovulation, and endocrine variance in women. As from the World Health Organisation, PCOS affects more than 116 million women globally. Patients with irregular periods and clinical indications of hyperandrogenism, such as acne, seborrhea, hirsutism, irregular menses, infertility, and alopecia, are suspected of having polycystic ovarian syndrome, a "multispeciality" illness. It is now widely acknowledged that oxidative stress plays a crucial part in the pathogenesis of numerous illnesses, including PCOS. OS is thought to have close interactions with PCOS characteristics, including insulin resistance (IR), hyperandrogenemia, and chronic inflammation. Although highly complicated antioxidant enzyme and non-enzymatic systems regulate intracellular reactive oxygen species formation and propagation, knowing the mechanisms that underlie oxidative stress is crucial to the development of PCOS prevention and treatment options. Management should prioritise encouraging employees, educating the public, resolving psychological issues, and highlighting a healthy lifestyle with appropriate medical treatment. Long-term metabolic problems need to be monitored and managed as part of standard therapeutic care. To help with early diagnosis, appropriate investigation, routine screening, and treatment of this common illness, comprehensive evidence-based guidelines are required. The research suggests that phytoestrogen rich herbal extracts reduce hyperandrogenism, insulin resistance, and ovarian weight while increasing ovulation. As a result, these plants may have some effect on the levels of various hormones in the serum as well as ovarian weight and morphology, which presents a chance to research and find novel bioactive compounds.
Downloads
References
2. Jeshica B et al. A review: Brief insight into Polycystic Ovarian syndrome. Endocrine and Metabolic Science 2021; 3: 100085.
3. Bharathi, RV et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertility Society Journal 2017; 22(4):313–316.
4. Rojas J et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med 2014; 719050.
5. Cheung LP. Polycystic ovary syndrome: not only a gynaecological disease. J Paediatr Obstet Gynaecol 2008; 125-31.
6. Diamanti-Kandarakis Eet al. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update 2005; 11:631-43.
7. Azziz Ret al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016; 2:16057.
8. Zawadski J et al. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992; 377-84.
9. Goodarzi MO et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-31.
10. Azziz R et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. FertilSteril 2009;91:456-88
11. Azziz R et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-45.
12. Masoumeh M. Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review. International Journal of Preventive Medicine 2019, 10: 86; 1-7.
13. Tuso P et al. A plant based diet, atherogenesis, and coronary artery disease prevention. Perm J 2015;19:62 7.
14. Sabuncu T et al. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001;34:407 13.
15. Zhang D et al. The effects of oxidative stress to PCOS. Sichuan da xuexuebao. Yi xue ban Journal of Sichuan University2008;39:421-3.
16. Savic RadojevicA et al. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non obese women with polycystic ovary syndrome. Hormones (Athens) 2015;14:101 8.
17. Murri Met al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta analysis. Human Reprod Update 2013;19:268 88.
18. Tao Z et al. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxidative Medicine and Cellular Longevity2016; 1-14.
19. Nina M et al. Polycystic ovarian syndrome. Indian Journal of Dermatology, Venereology, and Leprology 2013; 79(3).
20. Azziz Ret al. Androgen Excess Society: Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91:4237-4245.
21. Teede Het al. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab 2007, 18:273-279.
22. Galletly Cet al. A group program for obese, infertile women: weight loss and improved psychological health. JPsychosom Obstet Gynaecol 1996; 17:125-128.
23. Moran LJet al. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009; 92:1966-1982.
24. Meyer C et al. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007; 30:471-478.
25. Aliasghar M et al. Polycystic ovaries and herbal remedies: A systematic review. JBRA Assisted Reproduction 2023;27(1):85-91.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.